Results showed that inhibition of p38 signaling could partially reverse the mast cell-induced expression of p-p38, p53 and p21, with partially restoration of PCa cells sensitivity to docetaxel treatment (Figure 3B–3C). The gene discussed is TP53; the disease is posterior cortical atrophy.